The pathway from basic research to practices and policies Tim Grant and Gloria Crispino-O’Connell 11 th February 2011 - HSE.

Slides:



Advertisements
Similar presentations
The Statisticians Role in Pharmaceutical Development
Advertisements

429 pharmaceutical care Plan Refa’a AlAjmi. Goal of therpay A goal of therapy is the desired response or endpoint that you and your patient want to achieve.
Implementation Research: Using Science to Guide Implementation of Evidence-Based Practices Brian S. Mittman, PhD Director, VA Center for Implementation.
Using Statistics Effectively in Statistics Education Research Sterling C. Hilton Brigham Young University.
ODAC May 3, Subgroup Analyses in Clinical Trials Stephen L George, PhD Department of Biostatistics and Bioinformatics Duke University Medical Center.
Elements of a clinical trial research protocol
Clinical Trials Medical Interventions
CORE COMPETENCIES IN CLINICAL & TRANSLATIONAL RESEARCH: The Child Health Perspective I. Clinical & Translational Research Questions: Extract information.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development Critical Path.
The Pursuit of Better Medicines through Genetic Research Terri Arledge, DVM US Department Head Drug Development Genetics.
The ICH E5 Question and Answer Document Status and Content Robert T. O’Neill, Ph.D. Director, Office of Biostatistics, CDER, FDA Presented at the 4th Kitasato-Harvard.
Problem Analysis Intelligence Step 2 - Problem Analysis Developing solutions to complex population nutrition problems (such as obesity or food insecurity)
Chapter 3 Preparing and Evaluating a Research Plan Gay and Airasian
Engaging the C-suite to Advance Pharmacy Practice Providing quality patient care through progressive pharmacy practice Evaluation of Unit-based Pharmacy.
The Nurse Practice Act.  Defines the Nurse Practice Act and its function  Describes how the Nurse Practice Act applies to the RN Scope of Practice Objectives.
Introduction to Standard 2: Partnering with consumers Advice Centre Network Meeting Nicola Dunbar October 2012.
Howard Fillit, MD Executive Director Improving Animal Trials for Alzheimer’s Disease: Recommendations for Best Practices.
Victoria E. Aldridge, Pharm.D. JUSTIFICATION OF CLINICAL STAFFING Victoria E. Aldridge, Pharm.D.
Prevention of Falls In Older People A Community of Practice for Falls A collaborative project between NHS Quality Improvement, NHS Education and NHS Health.
Valid Informed Consent Education Pilot Project 2 nd Annual Nursing Research & Evidence-Based Practice Symposium Sandra Knowlton-Soho, MS, RN Sara Simeone,
Moving from Development to Efficacy & Intervention Fidelity Topics National Center for Special Education Research Grantee Meeting: June 28, 2010.
Cognitive Interviewing for Question Evaluation Kristen Miller, Ph.D. National Center for Health Statistics
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 18 Mixed Methods and Other Special Types of Research.
Gil Harari Statistical considerations in clinical trials
1 Value Assessment of Development-Stage Assets Pharmaceutical Products, Medical Devices, and Related Intellectual Property Frank S. Castellana, M.D., Eng.Sc.D.
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
INTRODUCTION TO RA.
Grant Writing Workshop for Research on Adult Education Elizabeth R. Albro National Center for Education Research.
Dr Samira Alsenany.  Knowledge must be translated into clinical practice to improve patient care and outcomes  The understanding of care based on evidence.
Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.
Decision Support as a Clinical Skill Module V: Communicating Risk Information Last update: September 2008.
Community Health Needs Assessments for Nonprofit Rural Hospitals: Next Steps Dave Palm College of Public Health Annual Conference of the Nebraska Rural.
EHR Goal Setting and Impact on Quality of Care
Meeting of the High Level Group on Administrative Burdens Dr. Johannes Ludewig Chairman of the Nationaler Normenkontrollrat Brussels, 23 July 2013.
Humanitarian Use Devices September 23, 2011 Theodore Stevens, MS, RAC Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and.
Areej Jouhar & Hafsa El-Zain Biostatistics BIOS 101 Foundation year.
Developing medicines for the future and why it is challenging Angela Milne.
The Nursing Process ASSESSMENT. Nursing Process Dynamic, ongoing Facilitates delivery of organized plan of nursing care Involves 5 parts –Assessment –Diagnosis.
NAS/IOM Review of Rare Diseases Research and Orphan Products Development - USA Timothy Cote, M.D., MPH Director, Office of Orphan Products Development.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 5 Theory, Research, and Evidence-Based Practice.
NIHR Research Design Service London Enabling Better Research Dr Caroline Burgess General Adviser 13 th November 2013.
Evaluation, Trials and Studies Coordinating Centre Developing Sight Loss and Vision research questions: a funder’s perspective Anna Tallant Scientific.
Feasibility Study.
Health Reform: Local Safety Net Implications Karen J. Minyard, Ph.D., Executive Director, Georgia Health Policy Center, Georgia State University.
1 Study Design Issues and Considerations in HUS Trials Yan Wang, Ph.D. Statistical Reviewer Division of Biometrics IV OB/OTS/CDER/FDA April 12, 2007.
Inside Clinical Trials ® ALL RIGHTS RESERVED. What is a clinical trial? ALL RIGHTS RESERVED.
Research for Nurses: Methods and Interpretation Chapter 1 What is research? What is nursing research? What are the goals of Nursing research?
Programme Grants for Applied Research and Programme Development Grants Programmes Supporting a successful application September 2014.
Framing a research question Chitra Grace A Scientist- C (PGDHE) NIE, Chennai RM Workshop for ICMR Scientists 01/11/2011.
NIAMS Extramural Scientific Planning Retreat 2013 April 4, 2013 Session 1: Strategies for Successful Rare Disease Clinical Trials.
School & Community Wellness Partnerships Becky Kennedy, M.Ed. Program Coordinator Coordinated School Health Programs Indiana School Health Network/ Indiana.
Methodological Issues in Implantable Medical Device(IMDs) Studies Abdallah ABOUIHIA Senior Statistician, Medtronic.
What is Research Design? RD is the general plan of how you will answer your research question(s) The plan should state clearly the following issues: The.
Developing, Pilot Testing & Evaluating RiskMAP Interventions Annette Stemhagen, DrPH, FISPE Vice President UBC Epidemiology & Risk Management The FDA Regulatory.
Research Strategy: Approach Frank Sellke, MD Division of Cardiothoracic Surgery Brown Medical School Providence RI AATS Grant Course 2011.
Methodological and Statistical Considerations in Clinical Research Dr. Gloria Crispino, CStat CMath Copy Rights; Do not reproduce without authorization.
Health Sector Functional Review Context & Preliminary Results for Policy Options Discussion Health Sector Workshop Belgrade – March 24, 2016 World Bank.
Building an Evidence-Based Nursing Practice
Critically Appraising a Medical Journal Article
The Essentia Institute of Rural Health (EIRH) is
MRC’s Translational Research Funding
Clinical Trials Medical Interventions
Unit 6 Research Project in HSC Unit 6 Research Project in Health and Social Care Aim This unit aims to develop learners’ skills of independent enquiry.
Strategies to incorporate pharmacoeconomics into pharmacotherapy
NAPLEX preparation: Biostatistics
Clinical Trials.
Sue Todd Department of Mathematics and Statistics
COMPUS Overview Denis Bélanger Heather Bennett Steve Graham
Introduction to Basic Research Methods
How Should We Select and Define Trial Estimands
Presentation transcript:

The pathway from basic research to practices and policies Tim Grant and Gloria Crispino-O’Connell 11 th February HSE

2 CSTAR - Who we are  Founded by a group of academics and health researchers, CSTAR is a partnership of 4 universities, UCD, TCD, NUIG and UL.  Supported by the HRB, opened for business on 1 st September It is led by Prof. Leslie Daly, UCD.  Board of Directors and International Advisory Group.  1 Director, 3 Biostatisticians and 1.5 Administrator

3 CSTAR - What we do  Provide biostatistical and methodological support to health research studies, both quantitative and qualitative.  Areas of support include: –Study design –Methodological Section of grant applications –Statistical Analysis –Interpretation of results for publication

4 The translational Continuum Source: Canadian Institute of Public Health The inability to overcome the death valleys is due to multiple factors, including the lack of methodological support.

5 The context of health research  Development/evaluation of : –Drugs –Medical Devices –Diagnostics tests –Therapy protocols –Health Services Practices –Health status  What is Clinical Research? –Study of drugs, devices, diagnostics and therapies in human subjects with the intent to discover potential beneficial effects and/or determine its safety and efficacy.  Who does it involve? – Collaboration of many personnel with a variety of skills e.g.; medics, scientists, statisticians, nurses, data managers, pharmacists etc.

6 Drug Development 1 In 10,000 Succeed (to market/practice) Average Time: 10-18Years Average Cost: €500 Million to €2 billion (<20% of sales) 100,000 Examined by FDA and similar bodies (Preclinical Evaluation) 100 Tested in Humans 10 Marketed Drugs 2 Drugs Return a Profit

7

8 Biomarkers Development Source: MMI – The Irish Biomarker Network Inaugural Workshop

9 In all application forms… ..describe clearly all stages of the study design - rationale for sampling strategy, justification of sample size and power calculation, full details on the design chosen to evaluate an intervention, methods of data collection, measures and techniques of analysis for quantitative and qualitative designs. Source: HRB Health Research Award 2010

10 Preparation and Perspiration!  A well thought out study should have the following methodological documents completed before recruitment/data collection starts: –Study/Research Protocol –Data Management Plan –Statistical Analysis Plan –Study Report Plan

11 Design: Research question(s)  Primary and secondary objectives –Generic  Primary and secondary questions –Specific  Primary and secondary variables –More specific (parameters, measurements, data)  Primary and secondary analysis –Nail it!

12 Statistical Analysis… is the easy part!  Estimation  Confidence Intervals  Hypothesis Testing  Assumption Testing

13 Cost/Benefit and Effectiveness  A great obstacle to a better health system (drugs, therapies, services etc.) is the difficulty in estimating the costs and benefits of any intervention.  A cost and benefit study start with a research question!  Fundamental conceptual assumptions: –What do we include as costs and benefits? –‘How far’ do we measure the impact of an intervention? i.e. Direct and indirect benefits –What methodology do we use to quantify them? –Who should take the burden of such costs? The government, the industry or the patient?

14 Direct and Indirect Benefits and Costs Monetary value of key parameters: -Life -Better quality of life and loss of life -Prevention of late stage of disease vs the cost of implementing a new therapy -Impact on families, children.. -Social costs Methodologies are driven by policies and practices. Many examples in the literature: Sir Nicholas Stern (UK) 2006, Orley Ashenfelter (Princeton) and Michael Greenstone (Chicago) 2002.